Fair-Value Report — China Merchants China Direct Investments (0133.HK)
Insider Signal
| Field | Detail |
|---|---|
| Filer (holder) | TFI Asset Management (Cayman) Ltd. — 天風國際資產管理有限公司, HK subsidiary of Tianfeng Securities Co., Ltd. (601162.SS), a PRC securities firm listed on Shanghai Stock Exchange. Holds Type 9 (asset management) SFC licence. This is a licensed external fund manager, NOT a broker, custodian, nominee, or related party of China Merchants Group. |
| Reason code | 1101 / 1103 — On-exchange and/or off-exchange open-market purchase of existing shares at prevailing market price |
| Transaction date | June 26, 2026 — one day after CMCDI announced expiry of CMCIM's Investment Management Agreement and appointment of new CIO / Administrative GM / CFO (June 25 announcement) |
| Shares acquired (est.) | ~3.11 million shares at ~HK$19.44 per share |
| Total consideration | HK$60,497,280 (~HK$60.5M) |
| Holding before | ~9.77% of issued share capital |
| Holding after | 11.81% — a very substantial existing position further enlarged |
| Signal quality | Genuine open-market accumulation. NOT a subscription of new shares, placing, rights issue, pledged-share artifact, intra-group reshuffle, or employee scheme. TFI/Tianfeng is entirely independent of China Merchants Group and First Eastern Investment Group. The timing — buying one day after a management-internalization announcement that triggered a share-price pullback — signals conviction on the governance transformation. |
| Caveat | The HKEX DI form designates TFI as a clients account, meaning TFI acts as fund manager deploying client capital, not proprietary capital. This slightly reduces the "skin-in-the-game" purity of the signal, but TFI's 11.81% stake still represents a very large concentrated bet by a professional institutional manager. |
Verified Market Snapshot
Business Overview
China Merchants China Direct Investments Ltd. (CMCDI, 0133.HK) is a Hong Kong-listed, closed-end investment fund structure backed by China Merchants Group, one of China's largest state-owned enterprise conglomerates (founded 1872). CMCDI was established to make long-term direct investments in PRC-based companies across financial services, information technology (AI, fintech, healthcare), cultural industries, and emerging sectors.
Until June 30, 2026, CMCDI was externally managed by China Merchants China Investment Management Limited (CMCIM), a joint venture between China Merchants Group and First Eastern Investment Group (led by Victor Chu). On June 25, 2026 — one day before the DI filing that triggered this analysis — CMCDI announced the expiry of the CMCIM Investment Management Agreement and the concurrent appointment of a new internal team (Chief Investment Officer, Administrative General Manager, Chief Financial Officer). This marks a transition from external to self-managed governance, effective July 1, 2026.
This transition is the central catalyst: shareholders had previously rejected a proposed 3-year extension of the CMCIM mandate (indicating dissatisfaction), and the company subsequently extended CMCIM for only 6 months (Jan–Jun 2026) while transitioning to internal management. The management fee under the final 6-month agreement was capped at HK$8M total (about 0.12% of NAV annually), so the financial benefit of internalization is modest. The real driver of any discount-narrowing thesis is governance improvement, shareholder alignment, and market confidence, not fee savings.
Portfolio (Dec 31, 2025 — Most Recent Audited)
| Holding | Type | Sector | Value (Dec 31, 2025) | % of Dec 31 NAV | Current Status / Notes |
|---|---|---|---|---|---|
| China Merchants Bank (3968.HK) | Listed (HKEX / A-share) | Banking | US$331M | 39.7% | H-share at HK$45.26 (Jun 23, 2026); down from ~52-week high of HK$56.30. Largest holding and key NAV swing factor. |
| China Credit Trust Co., Ltd. | Unlisted | Trust / Finance | US$188M | 22.5% | Privately held trust company; illiquid. One of China's largest trust companies. Valuation is book-based, not mark-to-market. |
| Arashi Vision Inc. (688775.SS) | Listed (SSE STAR) | Consumer Tech (cameras) | US$187M | 22.4% | Insta360 maker. Stock at CNY 131.85 (Jun 26, 2026) — near 52-week low CNY 131.50 — vs ATH CNY 377.77 (Sep 2025). Estimated current stake value: ~US$95M (approx. 50% decline from year-end). HIGH RISK to near-term NAV. |
| iFLYTEK Co., Ltd. (002230.SZ) | Listed (A-share) | AI / Speech Tech | US$49M | 5.9% | China's leading AI speech platform. Listed Shenzhen A-share. |
| Xunfei Healthcare Technology | Listed (SSE STAR) | Healthcare / AI | US$43M | 5.2% | AI-powered healthcare subsidiary of iFLYTEK. |
| NBA China, L.P. | Unlisted (PE) | Sports / Media | US$39M | 4.7% | Minority stake in NBA China operations. Illiquid, long-horizon. |
| Pony AI (formerly) | Sold post year-end | Autonomous Driving | — | — | Disposed in early 2026 for US$18.31M proceeds; removed from portfolio. |
| JIC Leasing (pending) | Pending sale | Leasing / Finance | — | — | Agreed disposal ~US$38.68M pending; will convert to cash on completion. |
| Other holdings / cash | Various | Mixed | ~US$90M | ~10.8% | Residual positions + cash; JIC Leasing proceeds and Pony AI proceeds to be added to cash. |
Source: CMCDI 2025 Annual Report (December 31, 2025). Current prices: CMB 3968.HK at HK$45.26 (Jun 29, 2026, StockAnalysis); Arashi Vision 688775.SS at CNY 131.85 (Jun 26, 2026, StockAnalysis). Post-year-end events confirmed via minichart.com.sg/2026/04/23 CMCDI AR summary.
Valuation: SOTP / Discount-to-NAV Methodology
Method rationale: CMCDI is a closed-end investment fund holding a mix of listed and unlisted PRC assets. The correct primary method is discount-to-NAV (SOTP), not a traditional revenue-based DCF. The NAV is the intrinsic anchor; the discount at which shares trade reflects market confidence in management, portfolio quality, liquidity, and governance. Management internalization is the key variable for discount narrowing. A supplementary P/E check is provided but is low-information given CMCDI's earnings come primarily from fair-value movements rather than recurring cash earnings.
WACC Reference (CAPM)
| Input | Value | Source |
|---|---|---|
| Risk-free rate (HK 10Y proxy, USD peg) | 3.80% | US 10Y approximate; HKD pegged to USD |
| Beta (vs HKEX) | 0.47 | StockAnalysis.com (5Y) |
| Equity Risk Premium (HK) | 5.50% | Damodaran implied ERP for HK |
| Country Risk Premium | 1.00% | HK-listed, PRC assets; modest uplift |
| Cost of Equity | 7.38% | CAPM output |
| Debt weight (nominal, nearly all-equity) | 2% | Investment holding structure |
| WACC | 7.32% | scripts/wacc.py output |
Scenario Analysis — NAV and Discount-to-NAV
Each scenario projects (a) the 12-month forward NAV per share and (b) the discount at which shares are expected to trade, reflecting the probability of successful management internalization and portfolio performance.
| Scenario | Weight | Key Assumptions | 12m NAV / Share (HKD) | Target Discount | Target Price (HKD) | Return vs HK$19.44 |
|---|---|---|---|---|---|---|
| Bull | 25% | Internalization succeeds; new team delivers clarity. CMB recovers to HK$52, Arashi Vision stabilizes at CNY 150. JIC Leasing/Pony proceeds deployed well. Discount narrows sharply as governance discount is removed. | HK$42 | 28% | HK$30.2 | +55% |
| Base | 50% | Partial improvement; new team credible but slow to prove. CMB stays around HK$48–50. Arashi Vision stabilizes ~CNY 135–140. Discount narrows moderately as market recognizes undervaluation. | HK$38 | 38% | HK$23.6 | +21% |
| Bear | 25% | Management transition rocky; key talent departs CMCIM, new internal team lacks portfolio knowledge. CMB falls to HK$40 on China macro stress. Arashi Vision drops to CNY 100. Discount stays wide (50%) as confidence erodes. | HK$32 | 50% | HK$16.0 | −18% |
| Probability-Weighted Fair Value | 0.25 × HK$30.2 + 0.50 × HK$23.6 + 0.25 × HK$16.0 | — | — | HK$23.4 | +20.4% |
Plus dividend yield of ~4.0% (HK$0.78 TTM, assuming maintained). Total return potential: approximately 24% over 12–18 months. Income while waiting for discount to narrow.
Reverse Read — What the Current Price Implies
At HK$19.44, the market prices in a permanent 48–52% discount to NAV. This is more severe than Fosun International (0656.HK, 78% discount but actively distressed with leverage and losses) on a quality-adjusted basis, and far wider than typical HK SOE investment holding discounts of 25–40%. To justify HK$19.44 in the base case, one would need to believe either (a) NAV deteriorates another 30% AND the discount stays at 40%, or (b) management internalization completely fails AND the portfolio marks down. Neither scenario is remotely the base case for a China Merchants Group-backed entity with US$834M in audited net assets and zero reported financial distress. The market appears to be pricing in excessive governance uncertainty — precisely the event that TFI/Tianfeng is betting on resolving.
Peer Comparison
For HK-listed investment holding/closed-end vehicles. Primary metric: Price/NAV (P/Book where NAV unavailable). Note: truly comparable pure closed-end fund peers are limited in HK; table below is the closest available set. Treat as directional cross-check only.
| Name | Ticker | Price (HKD) | Mkt Cap | P/NAV or P/B | NAV/Share | Dividend Yield | FY2025 Profit | Notes |
|---|---|---|---|---|---|---|---|---|
| CMCDI (Target) | 0133.HK | 19.44 | ~HK$2.96B | 0.48× | HK$40.18 (May 31) | 4.0% | US$190M profit | Internalization catalyst; zero financial distress; PRC PE + listed portfolio |
| China Everbright Ltd. | 0165.HK | 5.40 | HK$9.1B | ~0.5–0.7× book (est.) | N/A pub. | 1.85% | HK$(2.0B) loss | SOE financial holding; loss-making in 2025; broader mandate than CMCDI |
| CITIC Limited | 0267.HK | 11.70 | HK$342.7B | ~0.65× book (est.) | N/A pub. | 5.72% | HK$65.4B profit | Giant SOE conglomerate; operating businesses (not pure fund); P/E 5.3× |
| Fosun International | 0656.HK | 3.97 | HK$31.3B | 0.22× NAV | HK$18.1 | N/M | CNY (23.4B) loss | Private PE holding; heavily leveraged; in financial restructuring — distressed comp |
| Median (excl. CMCDI) | ~0.58× (est.) | |||||||
| CMCDI vs Median | −17% to median (est.) | |||||||
CMCDI trades at an estimated 17% below even the depressed median P/NAV/B of this peer group. The only true distressed comp (Fosun at 0.22×) explains why; CMCDI with zero leverage and profitable operations should logically trade at a premium to Fosun. The current discount is pricing in a risk level inappropriate for CMCDI's balance-sheet quality. Target is trading at approximately 17% discount to peer median P/NAV, which is NOT justified by fundamentals — CMCDI has superior balance-sheet quality and profitability vs the peer set.
Supplementary P/E Sanity Check
Low-information for investment holding cos (earnings are volatile mark-to-market). Presented for completeness only.
| Metric | Value | Note |
|---|---|---|
| FY2025 EPS (derived) | ~US$1.247 (HK$9.72) | US$189.94M ÷ 152.35M shares |
| Current P/E (trailing) | 2.0× TTM | HK$19.44 ÷ HK$9.72 |
| 3-Year Average Net Profit | ~US$105M | (FY25 US$190M + FY24 US$120M + FY23 US$6M) ÷ 3 |
| Normalized P/E (3Y avg) | ~3.6× | HK$2,961M ÷ (HK$105M × 7.80) |
| CITIC P/E (for context) | 5.3× | Source: StockAnalysis |
Even on normalized earnings, CMCDI trades below CITIC. This is directionally supportive but not the primary valuation method — earnings stability at CMCDI is low given fair-value accounting.
Conclusion
Rating: Speculative Buy | Fair Value: HK$23.4 | Price: HK$19.44 (Jun 26, 2026)
CMCDI presents a deep-discount-to-verified-NAV thesis with a specific near-term catalyst (management internalization) and evidence of institutional conviction (TFI/Tianfeng at 11.81% and growing). The 48–52% discount to NAV is extreme by any reasonable benchmark for a zero-leverage, China Merchants Group-backed investment vehicle with profitable operations.
The rating is Speculative rather than Moderate Buy because:
- Transition execution risk is real. The new internal team (CIO/AGM/CFO announced June 25, 2026) has no track record. CMCIM managed this portfolio for years; institutional knowledge transfer is uncertain.
- Arashi Vision (22% of Dec 31 NAV) is in steep decline — near its 52-week low of CNY 131.50 after falling from ATH CNY 377.77. Further decline would continue to weigh on NAV.
- China Merchants Bank (40% of Dec 31 NAV) is subject to China macro and property-sector credit risk; it has already declined ~20% from recent highs.
- TFI buys via a "clients account" — institutional not proprietary conviction.
- China policy and geopolitical risk remain elevated for PRC-focused investment portfolios.
However, the risk-reward is asymmetric in the buyer's favour: the bear case at HK$16.0 (−18%) is capped by the portfolio's hard asset value, while the bull case at HK$30.2 (+55%) is entirely plausible if the management transition restores investor confidence. The 4.0% dividend yield is paid while waiting.
Signal real. Discount real. Catalyst real. But execution uncertain. Size accordingly.
Key Risks
- Management transition failure: New internal team lacks CMCIM's institutional knowledge. Portfolio may underperform without experienced private equity practitioners.
- Arashi Vision (688775.SS) concentration and further decline: ~22% of Dec 31 NAV in a single listed stock near its 52-week low. Each 10% decline in Arashi Vision reduces estimated NAV by ~HK$1/share.
- China Merchants Bank (3968.HK) macro risk: Largest holding (~40% of Dec 31 NAV). Sensitive to China property-sector NPLs, regulatory pressure on bank dividends, and HK interest rate environment.
- Illiquid portfolio: China Credit Trust (US$188M) and NBA China (US$39M) are unlisted private assets. Their book values are not mark-to-market; actual realisable value may differ.
- Discount persistence: Discounts on HK investment holding companies can persist for years. No guarantee the internalization triggers near-term discount narrowing.
- Currency and geopolitical risk: NAV primarily in USD-denominated PRC assets; subject to Renminbi/HKD/USD movements and US–China policy risk.
- NAV staleness: Monthly NAV updates (not quarterly); the June 2026 NAV is not yet published. Investors must rely on estimated current NAV.
Sources
- CMCDI official website (cmcdi.com.hk) — NAV per share as at May 31, 2026: HK$40.18 (US$5.128)
- CMCDI 2025 Annual Report summary — minichart.com.sg/2026/04/23; portfolio as at Dec 31, 2025; total net assets US$834.65M; net profit US$189.94M
- CMCDI investor relations announcements — HKEX/cmcdi.com.hk: management internalization (Jun 25, 2026 announcement); CMCIM 6-month mandate (Dec 22, 2025 announcement)
- StockAnalysis.com — 0133.HK: price HK$19.44 (Jun 26, 2026), dividend TTM HK$0.78; 3968.HK: price HK$45.26 (Jun 29, 2026); 688775.SS: price CNY 131.85 (Jun 26, 2026); 0165.HK, 0267.HK, 0656.HK peer data
- OpenCorpData.com / GLEIF — TFI Asset Management Limited LEI 254900N4V5NBB8T60U35; Chinese legal name 天風國際資產管理有限公司; HK registration 39889594
- Tianfeng International Securities (tfisec.com, LinkedIn) — confirmed as HK subsidiary of Tianfeng Securities Co., Ltd. (601162.SS), holding Type 9 SFC licence
- TipRanks.com — CMCDI 2025 final dividend announcement; NAV update articles
- Longbridge.com — FY2025 financial data; income statement cross-check
- scripts/wacc.py — CMCDI WACC calculation: 7.32% (cost of equity 7.38%, beta 0.47, risk-free 3.80%, ERP 5.50%, CRP 1.00%)
- Primary language note: Key HKEX filings consulted in English; Chinese version binding for HK-incorporated entities. NAV figures from company website which publishes in both English and Chinese.
No redactions applied.
Published via wiis. Originals are encrypted at rest; this page reflects the redacted version. report abuse.
Discussion
No comments yet.